Eleven Biotherapeutics reported -835000 in EBIT for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Amgen AMGN:US $ 2176M 324M
Bayer BAYN:GR 2.28B 1.89B
Bristol Myers Squibb BMY:US $ 3197M 9M
Corcept Therapeutics CORT:US $ 31.43M 4.66M
Eleven Biotherapeutics EBIO:US -835000 9.8M
Eli Lilly And LLY:US $ 1650.5M 919.4M
Merk MRK:US $ 5711M 652M
Pfizer PFE:US $ 12099M 2104M
Ziopharm Oncology ZIOP:US $ -9085000 1.23M